Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BACE inhibitors
BACE inhibitors
Biogen, Eisai throw out remaining Alzheimer's BACE hope
Fierce Biotech
Fri, 09/13/19 - 10:45 am
Biogen
Eisai
Alzheimer's disease
BACE inhibitors
elenbecestat
aducanumab
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs
Xconomy
Thu, 07/11/19 - 11:15 pm
Alzheimer's disease
BACE inhibitors
Merck
Eli Lilly
AstraZeneca
Amgen
Novartis
Biogen Eisai
Eli Lilly backs away from Bace but not from novel Alzheimer’s targets
EP Vantage
Thu, 11/15/18 - 09:48 am
Eli Lilly
drug development
Alzheimer's disease
BACE inhibitors
Eli Lilly sweeps the rest of the BACE work out of the pipeline following their latest major setback on Alzheimer’s
Endpoints
Wed, 11/7/18 - 07:17 pm
Eli Lilly
Alzheimer's disease
BACE inhibitors
Eli Lilly and AstraZeneca Drop PhIII Alzheimer's Candidate – BACE Class May Be Done
CP Wire
Tue, 06/12/18 - 09:16 am
Eli Lilly
AstraZeneca
lanabecestat
Alzheimer's disease
BACE inhibitors
Janssen drops the BACE as Alzheimer’s candidate joins fail list
Fierce Biotech
Fri, 05/18/18 - 12:09 pm
JNJ
Janssen
BACE inhibitors
atabacestat
Alzheimer's disease
Merck just dashed the last remaining hopes for its industry-leading BACE drug for Alzheimer’s
Endpoints
Tue, 02/13/18 - 11:14 pm
Merck
BACE inhibitors
Alzheimer's disease
verubecestat
$13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market
Motley Fool
Mon, 11/21/16 - 02:35 pm
Alzheimer's disease
AstraZeneca
Biogen
Eli Lilly
Merck
Roche
BACE inhibitors
Eisai joins hands with Biogen on PhIII Alzheimer’s BACE trial
Fierce Pharma
Wed, 08/10/16 - 10:11 am
Eisai
Biogen
BACE inhibitors
clinical trials
Alzheimer's disease
E2609
AstraZeneca, Eli Lilly move closely watched BACE Alzheimer's trial into PhIII
Fierce Biotech
Fri, 04/8/16 - 10:59 am
AstraZeneca
Eli Lilly
BACE inhibitors
Alzheimer's disease
AZD3293
3 Leaders In Alzheimer's BACE Inhibition
Seeking Alpha
Wed, 12/2/15 - 11:05 am
Alzheimer's disease
Amgen
AstraZeneca
BACE inhibitors
Eli Lilly
Merck
Novartis
Lilly to Pay AstraZeneca $500 Million in Alzheimer’s Push
Bloomberg
Tue, 09/16/14 - 09:21 am
Eli Lilly
AstraZeneca
Alzheimer's disease
BACE inhibitors
AZD3293
Alzheimer's Needs Cures, Not Pyrrhic Victories
Motley Fool
Mon, 07/21/14 - 09:17 am
Alzheimer's disease
pimavanserin
Acadia
Sangamo BioSciences
Valeant Pharmaceuticals
Bexarotene
Merck
BACE inhibitors
AstraZeneca
solanezumab
Eli Lilly
AstraZeneca in partnering talks for Alzheimer drug
Yahoo/Reuters
Wed, 05/7/14 - 08:13 am
Alzheimer's disease
AstraZeneca
BACE inhibitors
Can These 2 Health Care Giants Overcome Big Pharma's Alzheimer's Struggles?
Motley Fool
Mon, 02/17/14 - 03:24 pm
Alzheimer's disease
Merck
AstraZeneca
BACE inhibitors
MK-8931
AZD3293
AstraZeneca takes on Merck in Alzheimer's drug race
Yahoo/Reuters
Thu, 02/6/14 - 09:57 am
AstraZeneca
Merck
Alzheimer's disease
AZD3293
BACE inhibitors
Why did Roche kill off its Alzheimer's program for the BACE inhibitor RG7129?
Fierce Biotech
Fri, 12/13/13 - 10:51 am
Roche
BACE inhibitors
Alzheimer's disease
RG7129
Merck Hopes Alzheimer's Drug Fares Better Than Competitors
TheStreet.com
Thu, 09/5/13 - 08:50 am
Merck
Alzheimer's disease
Pfizer
Eli Lilly
JNJ
bapineuzumab
solanezumab
BACE inhibitors
MK-8931
Merck maintains lead in BACE inhibitors for Alzheimer's
PM Live
Tue, 07/16/13 - 10:47 am
Merck
Alzheimer's disease
BACE inhibitors
MK-8931
New drug studies offer patients hope of treatment to slow Alzheimer's within several years
Yahoo/AP
Mon, 12/3/12 - 10:21 am
Alzheimer's disease
Merck
MK-8931
BACE inhibitors
Eli Lilly
Roche
TauRx
LMTX